TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28822974

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (3.5 μg/kg + 5 μg/kg/hour CRI)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (3.5 μg/kg + 3.5 μg/kg/hour CRI) and Butorphanol (20 μg/kg + 24 μg/kg/hour CRI)
Number of subjects: 6
Study: 24791752

Group type: EXPERIMENTAL
Intervention: Oral GSH 1,000 mg/day
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Oral GSH 250 mg/day
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 23499546

Group type: EXPERIMENTAL
Intervention: Imiquimod (16 weeks, three times a week)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Topical fluorouracil (16 weeks, twice a week)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Electrocautery (monthly for 4 months)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Imiquimod
Number of subjects: 246

Group type: COMPARATOR
Intervention: Topical fluorouracil
Number of subjects: 246

Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 246
Study: 21188380

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy with capecitabine and mitomycin C
Number of subjects: 49
Study: 19081416

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 8194

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 8194
Study: 17243139

Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 83

Group type: COMPARATOR
Intervention: LPS stimulation
Number of subjects: 83
Study: 10879716

Group type: EXPERIMENTAL
Intervention: Open low-field MR system (0.2 T)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard high-field MR system (1.5 T)
Number of subjects: 38
Study: 8878306

Group type: EXPERIMENTAL
Intervention: Flashbackers during flashbacks
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Subjects with persistent MAP psychosis
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Non-flashbackers
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (61 physically healthy prisoners)
Number of subjects: 56
Study: 2049239

Group type: EXPERIMENTAL
Intervention: Chlorocresol and chlorbutol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (as placebo)
Number of subjects: 8
Study: 6659894

Group type: EXPERIMENTAL
Intervention: Aspheric contact lens designs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional spherical design
Number of subjects: 0
Study: 30614066

Group type: EXPERIMENTAL
Intervention: Shared care group (quarterly check-ups by general practitioners)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (mono-sectorial management in a specialized outpatient clinic, quarterly check-ups by endocrinologists)
Number of subjects: 140
Study: 29161523

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 202

Group type: COMPARATOR
Intervention: Nonpropranolol Control
Number of subjects: 202
Study: 26581884

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 95

Group type: COMPARATOR
Intervention: Tirofiban
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Ticagrelor and Tirofiban
Number of subjects: 95
Study: 24655569

Group type: EXPERIMENTAL
Intervention: VR of a natural environment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VR of an urban environment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study: 22151078

Group type: EXPERIMENTAL
Intervention: Live donor (LD) liver transplantation
Number of subjects: 295

Group type: COMPARATOR
Intervention: Deceased donor (DD) liver transplantation
Number of subjects: 295
Study: 19933409

Group type: EXPERIMENTAL
Intervention: B-type natriuretic peptide (BNP) testing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-BNP group (control)
Number of subjects: 0
Study: 18034397

Group type: EXPERIMENTAL
Intervention: Fixed combination therapy of dexamethasone and gentamicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Separate application of dexamethasone and gentamicin sulfate
Number of subjects: 0
Study: 16182897

Group type: EXPERIMENTAL
Intervention: Home visits (n=175)
Number of subjects: 350

Group type: COMPARATOR
Intervention: No home visits (n=175)
Number of subjects: 350
Study: 11913598

Group type: EXPERIMENTAL
Intervention: Sodium supplementation
Number of subjects: 112
Study: 10190422

Group type: EXPERIMENTAL
Intervention: Ramipril therapy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 67
Study: 17974421

Group type: EXPERIMENTAL
Intervention: 1‐alpha(OH) vitamin D3 (0.25 mcg twice a day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo with calcium (500 mg daily)
Number of subjects: 20
Study: 2167280

Group type: EXPERIMENTAL
Intervention: Radical surgery or optimal debulking
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Suboptimal debulking and exploratory laparotomy
Number of subjects: 361

Group type: COMPARATOR
Intervention: Radical surgery
Number of subjects: 361

Group type: COMPARATOR
Intervention: Optimal tumor reduction
Number of subjects: 361

Group type: COMPARATOR
Intervention: Suboptimal tumor reduction
Number of subjects: 361

Group type: COMPARATOR
Intervention: Exploratory laparotomy
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Secondary tumor reduction
Number of subjects: 361

Group type: COMPARATOR
Intervention: No secondary tumor reduction
Number of subjects: 361
Study: 30883986

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (PEI video/booklet)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control (factsheet)
Number of subjects: 119
Study: 29658314

Group type: EXPERIMENTAL
Intervention: Cold recruitment approach (phone calls to companies on a purchased list)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Lukewarm recruitment approach (phone calls to a list of eligible companies provided by a health insurer)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Warm recruitment approach (personal referrals from local health insurers and brokers)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cold recruitment approach
Number of subjects: 78
Study: 27082747

Group type: EXPERIMENTAL
Intervention: Behavioral treatments for substance use (specifics not provided)
Number of subjects: 194
Study: 25087414

Group type: EXPERIMENTAL
Intervention: Intravenous laser blood irradiation for 10 days, using a laser therapeutic device Matrix - VLOK with two radiating heads (KI-VLOK-63 and KI-VLOK-365).
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 132
Study: 22353207

Group type: EXPERIMENTAL
Intervention: 3 exergames (high choice)
Number of subjects: 44

Group type: COMPARATOR
Intervention: 3 traditional games (high choice)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Choice (1 toy vs 3 toys)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Traditional games
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Exergames
Number of subjects: 44
Study: 22112211

Group type: EXPERIMENTAL
Intervention: Physiotherapy-led home based physical activity program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 17664246

Group type: EXPERIMENTAL
Intervention: Generic citalopram
Number of subjects: 20

Group type: COMPARATOR
Intervention: Celexa
Number of subjects: 20
Study: 16273348

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 15
Study: 12022320

Group type: EXPERIMENTAL
Intervention: Intervention groups (3 types)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study: 10084637

Group type: EXPERIMENTAL
Intervention: 1 mg/day risperidone
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: 2 mg/day risperidone
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: 0.5 mg/day risperidone
Number of subjects: 625

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 625
Study: 7474246

Group type: EXPERIMENTAL
Intervention: Topical timolol (0.5%) eye drops
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Topical timolol (0.5%) eye drops with oral quinidine (50 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 13
Study: 2270452

Group type: EXPERIMENTAL
Intervention: Paracetamol (i.v.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (i.v.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6780356

Group type: EXPERIMENTAL
Intervention: Acute ethanol ingestion (1.316 mol)
Number of subjects: 8
Study: 31711474

Group type: EXPERIMENTAL
Intervention: Nickel titanium rotary instruments (NiTi‐RIs)
Number of subjects: 775
Study: 28859091

Group type: EXPERIMENTAL
Intervention: Movement-to-music video program (from week 2 to week 8)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Children at home (instead of daycare/preschool)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Higher body mass index of mothers
Number of subjects: 228
Study: 25845393

Group type: COMPARATOR
Intervention: Standard of care arm
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Daily reminders via alarm and follow-up calls from peer-educators
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Home visits by peer-educators (in addition to second arm activities)
Number of subjects: 600
Study: 23868085

Group type: EXPERIMENTAL
Intervention: High sodium intake (250 mmol/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High sodium intake (250 mmol/day) during exercise
Number of subjects: 36
Study: 21334682

Group type: EXPERIMENTAL
Intervention: TVT Secur™ single incision sling
Number of subjects: 194

Group type: COMPARATOR
Intervention: TVT™ Obturator System
Number of subjects: 194
Study: 19058060

Group type: EXPERIMENTAL
Intervention: Balance-strategy training program (twice-weekly for 12 weeks)
Number of subjects: 50
Study: 17311976

Group type: EXPERIMENTAL
Intervention: Fermented milk containing 4 x 10(10) live cells of Lactobacillus casei strain Shirota
Number of subjects: 19
Study: 15289275

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) induced by administering capsules containing an amino acid mixture without tryptophan.
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham depletion using identical capsules containing hydrous lactose.
Number of subjects: 27
Study: 11125388

Group type: EXPERIMENTAL
Intervention: Rectus fascia
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Polypropylene mesh
Number of subjects: 50
Study: 9777688

Group type: EXPERIMENTAL
Intervention: Antidepressant therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional ordinary least squares regression
Number of subjects: 0
Study: 7849168

Group type: EXPERIMENTAL
Intervention: Inferior mesenteric artery reimplantation
Number of subjects: 10

Group type: COMPARATOR
Intervention: No inferior mesenteric artery reimplantation (Control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both groups (with and without reimplantation)
Number of subjects: 10
Study: 3240762

Group type: EXPERIMENTAL
Intervention: furosemide-retard/triamterene
Number of subjects: 10

Group type: COMPARATOR
Intervention: furosemide-retard
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: furosemide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: OH-TA-sulphate
Number of subjects: 10
Study: 29771362

Group type: EXPERIMENTAL
Intervention: Sleep condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wakefulness condition
Number of subjects: 0
Study: 27816437

Group type: EXPERIMENTAL
Intervention: Def‐EX (exercise‐induced 25% energy depletion)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Def‐EI (diet‐induced 25% energy depletion)
Number of subjects: 14
Study: 24211819

Group type: EXPERIMENTAL
Intervention: InSight cognitive training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 60
Study: 22784432

Group type: EXPERIMENTAL
Intervention: Optimized rapeseed oil (20 g/d)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard rapeseed oil (20 g/d)
Number of subjects: 59
Study: 21358372

Group type: EXPERIMENTAL
Intervention: computer-based intervention
Number of subjects: 309

Group type: COMPARATOR
Intervention: control group
Number of subjects: 309
Study: 18289455

Group type: EXPERIMENTAL
Intervention: Desflurane with remifentanil
Number of subjects: 64

Group type: COMPARATOR
Intervention: Isoflurane with remifentanil
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups (Desflurane and Isoflurane)
Number of subjects: 64
Study: 16497603

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT) using a nicotine skin patch for 2 weeks before the quit date, with doses of 0, 21, or 42 mg/24-hr after the quit date in combination with mecamylamine (10 mg/day).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine skin patch treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine skin patches with reduced-nicotine cigarettes
Number of subjects: 0
Study: 15651509

Group type: EXPERIMENTAL
Intervention: BIPAP
Number of subjects: 24

Group type: COMPARATOR
Intervention: PSV
Number of subjects: 24
Study: 11704711

Group type: EXPERIMENTAL
Intervention: Statin treatment (exact dosage and duration not specified)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 9397385

Group type: EXPERIMENTAL
Intervention: Continuous transdermal norethisterone acetate (NETA) 170 micrograms
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Continuous transdermal norethisterone acetate (NETA) 350 micrograms
Number of subjects: 774

Group type: COMPARATOR
Intervention: Sequential oral progestogen (1 mg norethisterone or 20 mg dydrogesterone/day)
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Low-dose transdermal progestogen
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Continuous progestogen (low-dose)
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: Continuous progestogen (high-dose)
Number of subjects: 774

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 774

Group type: COMPARATOR
Intervention: Oral progestogen group
Number of subjects: 774
Study: 7618387

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (40‐50 Gy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study: 3148789

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (12 mg/kg.day)
Number of subjects: 16

Group type: COMPARATOR
Intervention: carnitine-free TPN
Number of subjects: 16
Study: 29117340

Group type: EXPERIMENTAL
Intervention: Hispanics
Number of subjects: 522

Group type: COMPARATOR
Intervention: Non-Hispanic whites
Number of subjects: 522

Group type: COMPARATOR
Intervention: Non-Hispanic blacks
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Mental HRQL
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Physical HRQL
Number of subjects: 522
Study: 27390185

Group type: EXPERIMENTAL
Intervention: Increasing intensity (0-120% of watts corresponding to the ventilatory threshold)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Decreasing intensity (120-0%)
Number of subjects: 46
Study: 23213051

Group type: EXPERIMENTAL
Intervention: Video books with motion pictures, music, and sounds
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Static books without music or sounds
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Static stories with music or sounds
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Video stories without music or sounds
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Video books with music or sounds
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control condition (two stories with static illustrations without music or sounds)
Number of subjects: 52
Study: 23114461

Group type: EXPERIMENTAL
Intervention: Nintendo Wii training (WII)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 58
Study: 20606148

Group type: EXPERIMENTAL
Intervention: Glucosamine (1500 mg daily for 6 months)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo (daily for 6 months)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Glucosamine
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 18680606

Group type: EXPERIMENTAL
Intervention: Caseload (one-to-one) midwifery care
Number of subjects: 2008

Group type: COMPARATOR
Intervention: Standard low risk care
Number of subjects: 2008
Study: 16798633

Group type: EXPERIMENTAL
Intervention: Learned resourcefulness training (LRT)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Focused reflection reminiscence (FRR)
Number of subjects: 89
Study: 12887260

Group type: EXPERIMENTAL
Intervention: Interferon (IFN)‐beta treatment
Number of subjects: 0
Study: 10408819

Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Droperidol 1.25 mg
Number of subjects: 120
Study: 7627484

Group type: EXPERIMENTAL
Intervention: Dual energy X‐ray absorptiometry (DXA) scan of the spine and hip
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Broadband ultrasound attenuation (BUA) scan of os calcis
Number of subjects: 0

Group type: COMPARATOR
Intervention: None specified
Number of subjects: 0
Study: 2484835

Group type: EXPERIMENTAL
Intervention: Isoprinosine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Amantadine
Number of subjects: 30
Study: 70171

Group type: EXPERIMENTAL
Intervention: Cartoon (color)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Live action film (color)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pixilation film (color)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cartoon (black and white)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Live action film (black and white)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pixilation film (black and white)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Real human beings (as visual stimuli)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Animated characters (as visual stimuli)
Number of subjects: 70
Study: 31276804

Group type: EXPERIMENTAL
Intervention: Transition intervention (4 months long, focused on heart-transplant knowledge, self-care, self-advocacy, and social support)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 28273737

Group type: EXPERIMENTAL
Intervention: Titanium-nitride-oxide-coated bioactive stents (BAS)
Number of subjects: 827

Group type: COMPARATOR
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 827
Study: 25945760

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment with fixed appliances
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (without orthodontic treatment)
Number of subjects: 20
Study: 24345758

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 22490861

Group type: EXPERIMENTAL
Intervention: HIFU combined with gemcitabine
Number of subjects: 48

Group type: COMPARATOR
Intervention: HIFU alone
Number of subjects: 48
Study: 19413646

Group type: EXPERIMENTAL
Intervention: DL-RW (web-based self-help intervention)
Number of subjects: 378
Study: 17322143

Group type: EXPERIMENTAL
Intervention: Dapoxetine 60 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ethanol 0.5 g/kg
Number of subjects: 24
Study: 15356550

Group type: EXPERIMENTAL
Intervention: Standard dosimeter method (5 breath to total lung capacity)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Modified dosimeter challenge (submaximal inhalations to approximately 50% to 60% below TLC)
Number of subjects: 16
Study: 11590628

Group type: EXPERIMENTAL
Intervention: Rank-based methods for analysis of outcomes with rescue medication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multilevel regression model relating outcome to allocated treatment and rescue status
Number of subjects: 0
Study: 9850355

Group type: EXPERIMENTAL
Intervention: Dual X-ray absorptiometry (DXA)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Peripheral quantitative computed tomography (pQCT)
Number of subjects: 165
Study: 8022438

Group type: COMPARATOR
Intervention: Prostaglandin E2 (20 mg intravaginally every 3 hours)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Misoprostol (200 micrograms intravaginally every 12 hours)
Number of subjects: 55
Study: 3692908

Group type: EXPERIMENTAL
Intervention: Low fat diet (20% energy from fat)
Number of subjects: 31

Group type: COMPARATOR
Intervention: High fat diet (40% energy from fat)
Number of subjects: 31
Study: 29186982

Group type: EXPERIMENTAL
Intervention: Making Your Wishes Known (MYWK): Comprehensive ACP decision aid including education and values clarification.
Number of subjects: 285

Group type: COMPARATOR
Intervention: Basic ACP: state‐approved online advance directive plus brochure.
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: ACP done together with family members.
Number of subjects: 285

Group type: COMPARATOR
Intervention: ACP done by patients alone.
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Making Your Wishes Known (MYWK) vs Basic ACP
Number of subjects: 285
Study: 27424046

Group type: EXPERIMENTAL
Intervention: Cataract extraction with contact lens correction
Number of subjects: 114

Group type: COMPARATOR
Intervention: Implantation of an intraocular lens
Number of subjects: 114
Study: 24395021

Group type: EXPERIMENTAL
Intervention: Guanfacine (2 or 3 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 22383605

Group type: EXPERIMENTAL
Intervention: Instructional video CD (VCD) and study guide
Number of subjects: 2

Group type: COMPARATOR
Intervention: Live patient training (Control Group A)
Number of subjects: 2
Study: 20694776

Group type: EXPERIMENTAL
Intervention: Chinese drugs administered by both oral intake and retention enema (Group A)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Chinese drugs given by retention enema only (Group B)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Western medicine (Group C)
Number of subjects: 78